Who are the women reshaping biopharma R&D? Nominate them for Endpoints’ annual reportnews2025-06-09T11:00:36+00:00June 9th, 2025|Endpoints News|
Biopharma leaders carving a path for the industry’s LGBTQ+ communitynews2025-06-06T11:10:22+00:00June 6th, 2025|Endpoints News|
Endpoints 100 biotech survey: Welcome to the summer of biotech’s discontentnews2025-05-20T11:00:54+00:00May 20th, 2025|Endpoints News|
Big ambitions at Merck and AstraZeneca — along with a few giant pitfalls — reshape top ranks of the R&D 15news2025-04-01T11:00:51+00:00April 1st, 2025|Endpoints News|
Endpoints’ LGBTQ+ list: Nominate for 2025news2025-02-25T13:00:31+00:00February 25th, 2025|Endpoints News|
Biotech is still trying to make CRISPR a successnews2025-02-19T15:00:35+00:00February 19th, 2025|Endpoints News|
Endpoints winners and losers 2024: Best and worst biotech trendsnews2024-12-19T14:00:55+00:00December 19th, 2024|Endpoints News|
Recapping the Endpoints 100: The biotech industry braces itself for Trump 2.0news2024-12-12T13:56:48+00:00December 12th, 2024|Endpoints News|
